Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma

Published:2021-02-15 Issue:4 Volume:60 Page:611-615
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Okumoto Joe¹,Sakamoto Shinjiro¹,Masuda Takeshi¹,Yamaguchi Kakuhiro¹,Horimasu Yasushi¹,Miyamoto Shintaro¹,Nakashima Taku¹,Iwamoto Hiroshi¹,Fukushima Noriyasu²,Fujitaka Kazunori¹,Hamada Hironobu¹,Hattori Noboru¹

Affiliation:

1. Department of Molecular and Internal Medicine, Hiroshima University Hospital, Japan

2. Department of Hematology, Hiroshima University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/4/60_4241-19/_pdf

Reference18 articles.

1. 1. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 24: 143-150, 2010.

2. 2. Chapman AM, Sun KY, Ruestow P, Cowan DM, Madl AK. Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers. Lung Cancer 102: 122-134, 2016.

3. 3. Thai AA, Solomon BJ. Treatment of ALK-positive nonsmall cell lung cancer: recent advances. Curr Opin Oncol 30: 84-91, 2018.

4. 4. Open-label randomized PhaseIII Study of the Efficacy and Safety of CH5424802(AF802) in ALK-Positive Advanced or Recurrent Non-Small Cell Lung Cancer with Crizotinib control [Internet]. [cited 2019 Nov 19]. Available from: http://image.packageinsert.jp/pdf.php?mode=1&yjcode=4291032M1029

5. 5. Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician 69: 2599-2606, 2004.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alectinib-Induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma: Case Report and Literature Review;Case Reports in Clinical Medicine;2024

2. Tyrosine kinase inhibitor-induced immune hemolytic anemia; three different drugs in three separate cases;Journal of Oncology Pharmacy Practice;2023-09-19

3. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review;BMC Nephrology;2023-06-14

4. Alectinib-induced hemolytic anemia;Journal of Oncology Pharmacy Practice;2023-01-05

5. Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report;OncoTargets and Therapy;2023-01